Advertisement

Exercise After Acute Myocarditis

When and How to Return to Sports

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maron B.J.
        • Doerer J.J.
        • Haas T.S.
        • et al.
        Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006.
        Circulation. 2009; 119: 1085-1092
        • Corrado D.
        • Basso C.
        • Rizzoli G.
        • et al.
        Does sports activity enhance the risk of sudden death in adolescents and young adults?.
        J Am Coll Cardiol. 2003; 42: 1959-1963
        • Eckart R.
        • Shry E.
        • Burke A.
        • et al.
        Department of Defense Cardiovascular Death Registry G. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance.
        J Am Coll Cardiol. 2011; 58: 5
        • Eckart R.E.
        • Scoville S.L.
        • Campbell C.L.
        • et al.
        Sudden death in young adults: a 25-year review of autopsies in military recruits.
        Ann Intern Med. 2004; 141: 829-834
        • Harmon K.G.
        • Asif I.M.
        • Maleszewski J.J.
        • et al.
        Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: a decade in review.
        Circulation. 2015; 132: 10-19
        • Harmon K.G.
        • Asif I.M.
        • Maleszewski J.J.
        • et al.
        Incidence and etiology of sudden cardiac arrest and death in high school athletes in the United States.
        Mayo Clin Proc. 11th. 91. Elsevier, 2016: 1493-1502https://doi.org/10.1016/j.mayocp.2016.07.021
        • Harmon K.G.
        • Drezner J.A.
        • Maleszewski J.J.
        • et al.
        Pathogeneses of sudden cardiac death in national collegiate athletic association athletes.
        Circ Arrhythmia Electrophysiol. 2014; 7: 198-204
        • Holst A.G.
        • Winkel B.G.
        • Theilade J.
        • et al.
        Incidence and etiology of sports-related sudden cardiac death in Denmark—implications for preparticipation screening.
        Heart Rhythm. 2010; 7: 1365-1371
        • Papadakis M.
        • Sharma S.
        • Cox S.
        • et al.
        The magnitude of sudden cardiac death in the young: a death certificate-based review in England and Wales.
        Europace. 2009; 11: 1353-1358
        • Puranik R.
        • Chow C.K.
        • Duflou J.A.
        • et al.
        Sudden death in the young.
        Heart rhythm. 2005; 2: 1277-1282
        • Solberg E.E.
        • Gjertsen F.
        • Haugstad E.
        • et al.
        Sudden death in sports among young adults in Norway.
        Eur J Prev Cardiol. 2010; 17: 337-341
        • Maron B.J.
        • Thompson P.D.
        • Ackerman M.J.
        • et al.
        Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
        Circulation. 2007; 115: 1643-1655
        • Peretto G.
        • Sala S.
        • Rizzo S.
        • et al.
        Arrhythmias in myocarditis: state of the art.
        Heart Rhythm. 2019; 16: 793-801
        • Mahrholdt H.
        • Wagner A.
        • Deluigi C.C.
        • et al.
        Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.
        Circulation. 2006; 114: 1581-1590
        • Jain A.
        • Norton N.
        • Bruno K.A.
        • et al.
        Sex differences, genetic and environmental influences on dilated cardiomyopathy.
        J Clin Med. 2021; 10: 2289
        • Kuhl U.
        • Pauschinger M.
        • Noutsias M.
        • et al.
        High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction.
        Circulation. 2005; 111: 887-893
        • Committee W.
        • Gluckman T.J.
        • Bhave N.M.
        • et al.
        2022 ACC expert Consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of cardiology solution set oversight committee.
        J Am Coll Cardiol. 2022; 79: 1717-1756https://doi.org/10.1016/j.jacc.2022.02.003
        • Tejtel S.K.S.
        • Munoz F.M.
        • Al-Ammouri I.
        • et al.
        Myocarditis and pericarditis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
        Vaccine. 2022; 40: 1499-1511
      1. Clinical considerations: myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines among adolescents and young adults.
        (Available at:) (Accessed May 23, 2022)
        • Ferreira V.M.
        • Schulz-Menger J.
        • Holmvang G.
        • et al.
        Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations.
        J Am Coll Cardiol. 2018; 72: 3158-3176
        • Singer M.E.
        • Taub I.B.
        • Kaelber D.C.
        Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis.
        medRxiv. 2021;
        • Daniels C.J.
        • Rajpal S.
        • Greenshields J.T.
        • et al.
        Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry.
        JAMA Cardiol. 2021; 6: 1078-1087
        • Moulson N.
        • Petek B.J.
        • Drezner J.A.
        • et al.
        SARS-CoV-2 cardiac involvement in young competitive athletes.
        Circulation. 2021; 144: 256-266
        • Tom Shimabukuro M.
        • MPH M.B.A.
        COVID-19 vaccine safety updates advisory committee on immunization practices (ACIP).
        (Available at:) (Accessed February 15, 2022)
        • Cooper Jr., L.T.
        • Berry G.J.
        • Shabetai R.
        Idiopathic giant-cell myocarditis—natural history and treatment.
        N Engl J Med. 1997; 336: 1860-1866
        • Birnie D.H.
        • Nery P.B.
        • Ha A.C.
        • et al.
        Cardiac sarcoidosis.
        J Am Coll Cardiol. 2016; 68: 411-421
        • Ekström K.
        • Lehtonen J.
        • Nordenswan H.-K.
        • et al.
        Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries.
        Eur Heart J. 2019; 40: 3121-3128
        • Groeneweg J.A.
        • Bhonsale A.
        • James C.A.
        • et al.
        Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members.
        Circ Cardiovasc Genet. 2015; 8: 437-446
        • Cooper Jr., L.T.
        • Čiháková D.
        Do genes influence susceptibility to myocarditis?.
        American College of Cardiology Foundation, Washington DC2021: 593-594
        • Corrado D.
        • Link M.S.
        • Calkins H.
        Arrhythmogenic right ventricular cardiomyopathy.
        N Engl J Med. 2017; 376: 61-72
        • Marcus F.I.
        • McKenna W.J.
        • Sherrill D.
        • et al.
        Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.
        Circulation. 2010; 121: 1533-1541
        • Sen-Chowdhry S.
        • Syrris P.
        • Prasad S.K.
        • et al.
        Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.
        J Am Coll Cardiol. 2008; 52: 2175-2187
        • Ortiz-Genga M.F.
        • Cuenca S.
        • Dal Ferro M.
        • et al.
        Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies.
        J Am Coll Cardiol. 2016; 68: 2440-2451
        • Smith E.D.
        • Lakdawala N.K.
        • Papoutsidakis N.
        • et al.
        Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy.
        Circulation. 2020; 141: 1872-1884
        • Corrado D.
        • Marra M.P.
        • Zorzi A.
        • et al.
        Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria.
        Int J Cardiol. 2020; 319: 106-114
        • Zarate Y.A.
        • Hopkin R.J.
        Fabry's disease.
        Lancet. 2008; 372: 1427-1435
        • Frustaci A.
        • Verardo R.
        • Grande C.
        • et al.
        Immune-Mediated myocarditis in Fabry disease cardiomyopathy.
        J Am Heart Assoc. 2018; 7: e009052
        • Schultheiss H.-P.
        • Fairweather D.
        • Caforio A.L.
        • et al.
        Dilated cardiomyopathy.
        Nat Rev Dis primers. 2019; 5: 1-19
        • Coronado M.J.
        • Brandt J.E.
        • Kim E.
        • et al.
        Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.
        Am J Physiology-Heart Circulatory Physiol. 2012; 302: H1726-H1736
        • Onyimba J.A.
        • Coronado M.J.
        • Garton A.E.
        • et al.
        The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice.
        Biol Sex Differences. 2011; 2: 1-13
        • Tschöpe C.
        • Ammirati E.
        • Bozkurt B.
        • et al.
        Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.
        Nat Rev Cardiol. 2021; 18: 169-193
        • Navaratnarajah C.K.
        • Pease D.R.
        • Halfmann P.J.
        • et al.
        Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.
        J Virol. 2021; 95: e01368-21
        • Robinson S.M.
        • Tsueng G.
        • Sin J.
        • et al.
        Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers.
        PLoS Pathog. 2014; 10: e1004045
        • Gannagé M.
        • Dormann D.
        • Albrecht R.
        • et al.
        Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes.
        Cell Host & Microbe. 2009; 6: 367-380
        • Kim S.-J.
        • Syed G.H.
        • Khan M.
        • et al.
        Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence.
        Proc Natl Acad Sci. 2014; 111: 6413-6418
        • Kyei G.B.
        • Dinkins C.
        • Davis A.S.
        • et al.
        Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages.
        J Cell Biol. 2009; 186: 255-268
        • Taylor M.P.
        • Kirkegaard K.
        Modification of cellular autophagy protein LC3 by poliovirus.
        J Virol. 2007; 81: 12543-12553
        • Fiuza-Luces C.
        • Delmiro A.
        • Soares-Miranda L.
        • et al.
        Exercise training can induce cardiac autophagy at end-stage chronic conditions: insights from a graft-versus-host-disease mouse model.
        Brain Behav Immun. 2014; 39: 56-60
        • Fukuta H.
        • Goto T.
        • Wakami K.
        • et al.
        Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.
        Heart Fail Rev. 2019; 24: 535-547
        • Hosenpud J.D.
        • Campbell S.M.
        • Niles N.R.
        • et al.
        Exercise induced augmentation of cellular and humoral autoimmunity associated with increased cardiac dilatation in experimental autoimmune myocarditis.
        Cardiovasc Res. 1987; 21: 217-222
        • Kiel R.
        • Smith F.
        • Chason J.
        • et al.
        Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.
        Eur J Epidemiol. 1989; 5: 348-350
        • Reyes M.P.
        • Lerner A.M.
        Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis.
        Proc Soc Exp Biol Med. 1976; 151: 333-338
        • Tilles J.G.
        • Elson S.H.
        • Shako J.A.
        • et al.
        Effects of exercise on coxsackie A9 myocarditis in adult mice.
        Proc Soc Exp Biol Med. 1964; 117: 777-782
        • Coronado M.
        • Fajardo G.
        • Nguyen K.
        • et al.
        Physiological mitochondrial fragmentation is a normal cardiac adaptation to increased energy demand.
        Circ Res. 2018; 122: 282-295
        • Di Florio D.N.
        • Sin J.
        • Coronado M.J.
        • et al.
        Sex differences in inflammation, redox biology, mitochondria and autoimmunity.
        Redox Biol. 2020; 31: 101482
        • Caforio A.L.
        • Pankuweit S.
        • Arbustini E.
        • et al.
        Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
        Eur Heart J. 2013; 34: 2636-2648
        • Petek B.J.
        • Moulson N.
        • Baggish A.L.
        • et al.
        Prevalence and clinical implications of persistent or exertional cardiopulmonary symptoms following SARS-CoV-2 infection in 3597 collegiate athletes: a study from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA).
        Br J Sports Med. 2021; 56: 913-918
        • Martinez M.W.
        • Tucker A.M.
        • Bloom O.J.
        • et al.
        Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening.
        JAMA Cardiol. 2021; 6: 745-752
        • Cooper Jr., L.T.
        Myocarditis.
        N Engl J Med. 2009; 360: 1526-1538
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • et al.
        2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
        Circulation. 2013; 128: 1810-1852
        • Corrado D.
        • Zorzi A.
        • Cipriani A.
        • et al.
        Evolving diagnostic criteria for arrhythmogenic cardiomyopathy.
        J Am Heart Assoc. 2021; 10: e021987
        • Tschöpe C.
        • Cooper L.T.
        • Torre-Amione G.
        • et al.
        Management of myocarditis-related cardiomyopathy in adults.
        Circ Res. 2019; 124: 1568-1583
        • Berg J.
        • Kottwitz J.
        • Baltensperger N.
        • et al.
        Cardiac magnetic resonance imaging in myocarditis reveals persistent disease activity despite normalization of cardiac enzymes and inflammatory parameters at 3-month follow-up.
        Circ Heart Fail. 2017; 10: e004262
        • Al-Khatib S.M.
        • Stevenson W.G.
        • Ackerman M.J.
        • et al.
        2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society.
        J Am Coll Cardiol. 2018; 72: e91-e220
        • Kociol R.D.
        • Cooper L.T.
        • Fang J.C.
        • et al.
        Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association.
        Circulation. 2020; 141: e69-e92
        • Maron B.J.
        • Udelson J.E.
        • Bonow R.O.
        • et al.
        Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology.
        J Am Coll Cardiol. 2015; 66: 2362-2371
        • Weidemann F.
        • Niemann M.
        • Störk S.
        • et al.
        Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications.
        J Intern Med. 2013; 274: 331-341
        • McKinney J.
        • Connelly K.A.
        • Dorian P.
        • et al.
        COVID-19–myocarditis and return to play: reflections and recommendations from a Canadian working group.
        Can J Cardiol. 2021; 37: 1165-1174
        • Patriki D.
        • Baltensperger N.
        • Berg J.
        • et al.
        A prospective pilot study to identify a myocarditis cohort who may safely resume sports activities 3 months after diagnosis.
        J Cardiovasc Translational Res. 2021; 14: 670-673
        • Georgiopoulos G.
        • Figliozzi S.
        • Sanguineti F.
        • et al.
        Prognostic impact of late gadolinium enhancement by cardiovascular magnetic resonance in myocarditis: a systematic review and meta-analysis.
        Circ Cardiovasc Imaging. 2021; 14: e011492